NCT03656744: A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)
- State
- Completed
- Phase
- Phase 2
- People
- 101 taking part
- Started
- 26 Nov 2018
- Primary completion
- 7 Feb 2020
- Arms
- 500mg HTD1801, bid, 1000mg HTD1801, bid
- Results
- Posted on the registry
- 4 Sep 2018: Trial registered
- 26 Nov 2018: Trial started
- 9 Mar 2020: Trial completed
- 29 Dec 2021: Trial results posted